2018
DOI: 10.2174/1389202918666171005100549
|View full text |Cite
|
Sign up to set email alerts
|

Decoding Common Features of Neurodegenerative Disorders: From Differentially Expressed Genes to Pathways

Abstract: Background: Neurodegeneration is a progressive/irreversible loss of neurons, building blocks of our nervous system. Their degeneration gradually collapses the entire structural and functional system manifesting in myriads of clinical disorders categorized as Neurodegenerative Disorders (NDs) such as Alzheimer’s Disease, (AD), Parkinson’s Disease (PD), Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). NDs are characterized by a puzzling interplay of molecular and cellular defects affecting … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
15
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 74 publications
1
15
0
Order By: Relevance
“…Despite exhibiting a wide range of molecular and phenotypic heterogeneity, NDs share some general characteristics, such as protein misfolding and aggregation, mitochondrial dysfunction, dysregulation of similar molecular/cellular pathways and loss of chromatin dynamics 2 4 . Together, these similarities support convergence of heterogeneous NDs, and better insight into these common links will help target multiple NDs with potential unifying therapeutics 3 , 4 .…”
Section: Introductionmentioning
confidence: 82%
See 1 more Smart Citation
“…Despite exhibiting a wide range of molecular and phenotypic heterogeneity, NDs share some general characteristics, such as protein misfolding and aggregation, mitochondrial dysfunction, dysregulation of similar molecular/cellular pathways and loss of chromatin dynamics 2 4 . Together, these similarities support convergence of heterogeneous NDs, and better insight into these common links will help target multiple NDs with potential unifying therapeutics 3 , 4 .…”
Section: Introductionmentioning
confidence: 82%
“…Depending on the specific subset of neurons and/or the area of nervous system severely affected, NDs vary with respect to the molecular pathways underlying the disease and the subsequent clinical manifestations 1 . Despite exhibiting a wide range of molecular and phenotypic heterogeneity, NDs share some general characteristics, such as protein misfolding and aggregation, mitochondrial dysfunction, dysregulation of similar molecular/cellular pathways and loss of chromatin dynamics [2][3][4] . Together, these similarities support convergence of heterogeneous NDs, and better insight into these common links will help target multiple NDs with potential unifying therapeutics 3,4 .…”
mentioning
confidence: 99%
“…A recent study searching for genes differentially expressed in Parkinson’s, Alzheimer’s, frontotemporal dementia, and amyotrophic lateral sclerosis found three major hub genes, including EGFR, CDC42, and CREBBP. CREBBP is a histone acetylase that partners with CREB to increase histone acetylation and gene expression at CREB-binding sites [ 70 ]. Another intersectional study of genes differentially expressed in Parkinson’s and Huntington’s diseases implicated targets of CREB signaling [ 71 ].…”
Section: Args Epigenetic Regulation and Parkinson’s Disordersmentioning
confidence: 99%
“…Neurodegenerative diseases (NDDs) such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) are disabling, incurable disorders, often associated with aging. Progressive and irreversible loss of neurons, neuroinflammation and degeneration of cellular functions and structures often associated with oxidative stress, are common features of NDDs (Habib et al, 2018). NDDs have a profound impact on the life expectancy of individuals and the socio-economy of the world population (Group, 2017).…”
Section: Introductionmentioning
confidence: 99%